Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,293 papers from all fields of science
Search
Sign In
Create Free Account
sulfoquinovosylacylpropanediol
Known as:
SQAP propanediol
, sulfoquynovosylacylpropanediol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Glycolipids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Distribution and metabolism of 14C-sulfoquinovosylacylpropanediol (14C-SQAP) after a single intravenous administration in tumor-bearing mice
Tatsushi Ruike
,
Y. Kanai
,
+12 authors
K. Sakaguchi
Xenobiotica; the fate of foreign compounds in…
2019
Corpus ID: 3895875
Abstract Sulfoquinovosylacylpropanediol (SQAP) is a novel potent radiosensitizer that inhibits angiogenesis in vivo and results…
Expand
2015
2015
Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer
Y. Sawada
,
K. Omoto
,
Naoki Kohei
,
K. Sakaguchi
,
M. Miura
,
K. Tanabe
International journal of urology
2015
Corpus ID: 13569397
To examine the effects of combined treatment with sulfoquinovosylacylpropanediol and X‐ray irradiation on the remodeling of the…
Expand
2015
2015
Editorial Comment from Dr Wu to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer
B. Wu
International journal of urology
2015
Corpus ID: 45544987
In this issue of International Journal of Urology, Sawada et al. reported a novel use of sulfoquinovosylacylpropanediol (SQAP), a…
Expand
2015
2015
Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer
Y. Miyata
,
H. Sakai
International journal of urology
2015
Corpus ID: 939670
Numerous investigators have evaluated the genetic and molecular characteristics of cancer cells. In addition to cancer cells, the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE